Global Liver Institute
News
GLOBAL LIVER INSTITUTE
TROA Reintroduced, Veterans Health Advances, Hep C Bill Introduced, and Senate Considers Medicaid Cuts – Liver Health Policy Update
The House passed H.R. 1, the One Big, Beautiful Bill Act, sending the budget reconciliation package to the Senate.
GLI Works With Congress to Protect Veterans’ Health
Global Liver Institute (GLI), in close coordination with congressional staff, has worked tirelessly to ensure that veterans diagnosed with NASH/MASH have no barriers to their care and treatment.
Global Fatty Liver Day 2025: Elevating Liver Health in the Metabolic Health Conversation
On the second Thursday in June, Global Fatty Liver Day (formerly International NASH Day) spotlights one of the most widespread yet under-addressed health threats of our time: fatty liver disease, increasingly referred to as steatotic liver disease (SLD) in clinical settings. Hosted annually by Global Liver Institute (GLI), this public awareness campaign raises awareness of this silent epidemic and its deep roots in global metabolic health challenges.
GLI Supports the Reintroduction of the Treat and Reduce Obesity Act
Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act, which was recently introduced by Senators Bill Cassidy (R-LA) and Ben Ray Luján (D-NM).
Hep C Elimination Bill – Statement of Support
Global Liver Institute (GLI) proudly supports legislation (S. 1941) introduced by Senators Bill Cassidy (R-LA) and Chris Van Hollen (D-MD) aiming to implement a nationwide elimination program for the hepatitis C virus (HCV) in the United States.
Liver Health Insights, Events, and a Global Challenge – Fatty Liver Disease News
Global Fatty Liver Day is on June 12 – There’s Still Time to Get Involved!
Addressing Liver Cancer Disparities & Advancing Treatment – Liver Cancer News
This edition features a 5-year update on the Financial Toxicity Tumor Board Model, highlighting how multidisciplinary collaboration can reduce financial barriers to care.
First Ever Rare Liver Disease Patient Cured with Personalized Gene Therapy Treatment – Pediatric and Rare Liver Diseases News
Kristin Hatcher, Director of our Pediatric and Rare Liver Diseases Program, joined global leaders and the GLI team at the EASL Congress this May to elevate the conversation around rare liver diseases.
Together for Better Liver Health: WHA78 Side Event Unites Global Stakeholders to Strengthen Public Health Responses to Metabolic Disease
Global health leaders call for urgent, integrated action on the rising rates of metabolic liver disease during a high-level policy event held on the sidelines of the 78th World Health Assembly and co-hosted by Global Liver Institute (GLI), the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD).
Global Health Leaders Convene at WHA78 Side Event to Advocate for Steatotic Liver Disease as a Core Non-Communicable Disease
Leading health organizations, policymakers, and public health advocates will come together during the 78th World Health Assembly (WHA78) for a pivotal side event titled “Together for Better Liver Health – Strengthening Public Health Responses to Metabolic Disease”.
The Frontline Role of Primary Care in Hepatitis B Care
Chronic infection of the liver by hepatitis B virus (HBV) remains a significant public health concern in the U.S. and around the world, particularly among at-risk populations.
Congress returns with budget reconciliation at the top of the to-do list. – Liver Health Policy Update
Key House authorizing committees are slated to kick off markups on their respective budget reconciliation instructions that will be combined into a single reconciliation bill.